If approved, retatrutide could become the first triple hormone receptor agonist available for chronic weight management and several obesity-related conditions
Common physical causes include cardiovascular disease, diabetes, hormonal imbalances, and certain medications
Currently, it appears that samples of Mounjaro are not directly available in Canada for general distribution
[12] [2] The American Diabetes Association recommends individualized glycemic targets and emphasizes the importance of patient education regarding hypoglycemia recognition and management
The agency said the company failed to meet CGMP requirements, including implementing and adhering to its risk-based corrective and preventive action (CAPA) procedures
#### Note: Always consult a healthcare professional for personalized medical advice and before starting any new treatment